Rockwell Automation Joined Digital CMC Consortium
The firm joined the group to help standardize digital specifications for pharmaceutical development.
Updated on Oct. 9, 2026 in Biotech
Live Poll
Do you believe the digital standardization of drug development improves the industry for patients?
Rockwell Automation has officially joined the Digital CMC Consortium to support the industry-wide move toward modernized drug development workflows. The group focuses on replacing outdated, manual analogue processes with standardized digital solutions.
Why it matters
Current pharmaceutical development often relies on manual document-based methods that struggle to scale with the demands of personalized medicine. Adopting digital standards is considered necessary to improve efficiency and adapt to complex modern treatment protocols.
The Digital CMC Consortium now includes eight member organizations and has produced two standardized digital specifications in the past six months. These standards aim to replace traditional, manual document-based workflows.
The players
Rockwell Automation
This is a global industrial automation and digital transformation company that provides integrated control and information solutions.
Digital CMC Consortium
This is a collaborative industry group dedicated to creating common digital specifications for the pharmaceutical development sector.
The details
The consortium develops pre-competitive digital specifications to harmonize how pharmaceutical companies manage development data. By integrating digital automation, the group seeks to overcome the limitations inherent in legacy record-keeping.
Timeline
Rockwell Automation joined the consortium in October 2026.
The consortium produced two digital specifications over the past six months.
The Tech Race
The industry is currently transitioning away from the manual document-based workflows that have long dominated pharmaceutical development. This move reflects a broader technological arms race as companies seek to replace legacy systems with integrated digital platforms.
For industry professionals, this shift promises improved workflow efficiency and a reduction in the errors associated with legacy manual systems. These standardizations will eventually simplify the integration of new digital tools into pharmaceutical development pipelines.
The takeaway
The move toward standardized digital specifications is a critical step in enabling the next generation of complex medical treatments. Standardized data protocols are essential for scaling the production of personalized medicines efficiently.
Further reading
Learn more about the latest innovations in Biotech.
Source note: This article includes information reported by Mobile World Live.
Live Poll
Do you believe the digital standardization of drug development improves the industry for patients?
